Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Halaven Approved for Liposarcoma (February 4, 2016)

The United States Food and Drug Administration (FDA) has approved the chemotherapy agent Halaven (eribulin) for the treatment of liposarcoma. It’s the first drug approved for liposarcoma that has demonstrated... Continue Reading

Should all Breast Cancer Patients Be Treated With the Bone Health Drug Xgeva®? (February 4, 2016)

The bone health agent Xgeva® (denusomab) appears to delay the time to cancer progression and improve survival among early stage breast cancer patients treated with aromatase inhibitors. Its use should... Continue Reading

Colorectal Cancer: Year in Review (February 3, 2016)

After several years of exciting developments in colorectal cancer research and therapy, progress continued throughout 2015. The FDA approved a new drug to treat colorectal cancer, and much research has... Continue Reading

World Cancer Day: Share Your Story on CancerConnect (February 3, 2016)

February 4th is #WorldCancerDay. A truly global event taking place every year on 4 February, World Cancer Day unites the world’s population in the fight against cancer. It aims to save millions of preventable... Continue Reading

Prostate Cancer: Year in Review (February 2, 2016)

In 2015, the increased use of Oncotype DX prostate cancer test promoted changes in treatment received, resulting in greater recommendations and adoption of active surveillance. Also noteworthy is the research... Continue Reading

Survival Period for Esophageal Cancer Is Tied to Race and Income (February 1, 2016)

African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers. The... Continue Reading

Kyprolis® (Carfilzomib) Appears More Effective Than Velcade® (Bortezomib) In Patients With Relapsed Multiple Myeloma (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review When researchers with a Phase III trial directly compared Kyprolis in combination with low-dose Decadron® (dexamethasone)... Continue Reading

Important Step Toward Widespread Use Of Low-Dose Computed Tomography Lung Cancer Screening In The United States (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review One strategy for reducing the death rate from lung cancer is to increase the rate of early detection so that cancers are found... Continue Reading

Hormone Drug Arimidex® (Anastrozole) Cuts Postmenopausal Breast Cancer Risk By Half (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review The aromatase inhibitor Arimidex has been found to reduce the risk of breast cancer by 53 percent in high-risk postmenopausal... Continue Reading

Researchers Are Hopeful For Breakthrough In Treatment Of Relapsed Leukemia (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Patients with B-cell acute lymphoblastic leukemia (ALL), the most common type of ALL, have limited treatment options after... Continue Reading

Patients With Early-Stage Melanoma And Lung Cancer Among Those Standing To Benefit From Immunotherapy (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Immunotherapy, a type of biological therapy, is among the most promising areas of cancer treatment advances. This approach... Continue Reading

Encouraging News For Patients With Treatment-Resistant Lung Cancer (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Although lung cancer is still a deadly disease—responsible for more than 150,000 deaths each year in the United States alone—there... Continue Reading

Survival Improved In Advanced Prostate Cancer With Early Treatment With Chemotherapy Plus Hormonal Therapy (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review In a study conducted by researchers at the Dana-Farber Cancer Institute, the chemotherapy drug Taxotere® (docetaxel) administered... Continue Reading

Combination of Radiation and Chemotherapy Improves Survival For Certain Types of Brain Cancer (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Patients with a low-grade type of brain cancer known as glioblastoma multiforme (GBM) may live up to five and a half years... Continue Reading

“Precision Medicine” Moves Forward For More-Personalized Care (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Precision medicine (also known as targeted therapy) is an approach where treatments are matched to the genetic makeup of the... Continue Reading

Promising Advances For Patients With Chronic Lymphocytic Leukemia (January 28, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review A look at 10 of the most significant advances of the past year—progress that stands to benefit patients now and lays the... Continue Reading

Vectibix® Improves Survival in Colorectal Cancer, Demonstrates Importance of Tissue Testing (January 28, 2016)

The addition of Vectibix® (panitumumab) to best supportive care improves survival over best standard care alone among colorectal cancer patients who have stopped responding to chemotherapy. However, the... Continue Reading

New Treatment Identified for Locally Advanced Rectal Cancer Has Fewer Side Effects Than Current Standard (January 27, 2016)

The results from a comparative phase III clinical study reported by Polish investigators at the 2016 Gastrointestinal Cancers Symposium in San Francisco have identified an additional treatment option for... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS